BACKWARD BIFURCATION IN A MATHEMATICAL MODEL OF PI3K/AKT PATHWAYS IN ACUTE MYELOID LEUKEMIA

被引：1

作者：

Adi, Yudi Ari ^{[1
,2
]}

Aryati, Lina ^{[2
]}

Adi-Kusumo, Fajar ^{[2
]}

Hardianti, Mardiah Suci ^{[3
]}

机构：

[1] Univ Ahmad Dahlan, Fac Appl Sci & Technol, Dept Math, Yogyakarta 55191, Indonesia

[2] Univ Gadjah Mada, Fac Math & Nat Sci, Dept Math, Yogyakarta 55281, Indonesia

[3] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Internal Med, Yogyakarta 55281, Indonesia

来源：

ADVANCES IN DIFFERENTIAL EQUATIONS AND CONTROL PROCESSES | 2019年 / 21卷 / 02期

关键词：

AML; mathematical model; backward bifurcation;

D O I：

10.17654/DE021020183

中图分类号：

O29 [应用数学];

学科分类号：

070104 ;

摘要：

This paper investigates a mathematical model of the PI3K/AKT pathway in acute myeloid leukemia (AML) in the absence of protein dephosphorylation and AKT degradation. We perform a bifurcation analysis by using the bifurcation method, which is based on the use of the center manifold theory. We give an explicit condition for the existence of backward and forward bifurcations. Numerical simulations are presented to support analytical results and then discussed from both the mathematical and the medical perspectives.

引用

页码：183 / 199

页数：17

共 50 条

[1] A Dynamic Model of PI3K/AKT Pathways in Acute Myeloid Leukemia
Adi Y.A.
Adi-Kusumo F.
Aryati L.
Hardianti M.S.
Journal of Applied Mathematics, 2018, 2018
[2] Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia
Park, Sophie
Chapuis, Nicolas
Tamburini, Jerome
Bardet, Valerie
Cornillet-Lefebvre, Pascale
Willems, Lise
Green, Alexa
Mayeux, Patrick
Lacombe, Catherine
Bouscary, Didier
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (05): : 819 - 828
[3] Inhibiting PI3Kγ in acute myeloid leukemia
Stonestrom, Aaron J.
Levine, Ross L.
NATURE CANCER, 2024, 5 (07) : 958 - 959
[4] Evaluation of MAPK and PI3K/AKT Signaling Pathways In Adult Acute Lymphoblastic Leukemia
Loureiro, Gustavo
Kerbauy, Daniella Bahia
Chauffaille, Maria de Lourdes L. F.
Lee, Maria Lucia M.
Candido, Franciele B. M.
Silva, Marcal C. A.
Kimura, Eliza Y. S.
Guirao, Fabio P.
Rezende, Denise C.
Yamamoto, Mihoko
BLOOD, 2010, 116 (21) : 1329 - 1329
[5] The PI3K/Akt/mTOR pathway:: a new therapeutic target in the treatment of acute myeloid leukemia
Dos Santos, Cedric
Recher, Christian
Demur, Cecile
Payrastre, Bernard
BULLETIN DU CANCER, 2006, 93 (05) : 445 - 447
[6] Plantamajoside Inhibits the Growth of Acute Myeloid Leukemia Cells by Modulating NF-κB and PI3K/AKT Signaling Pathways
Zhou, Xiaolu
Wang, Guochuan
Wu, Qiongsheng
Yang, Mei
CURRENT TOPICS IN NUTRACEUTICAL RESEARCH, 2022, 20 (03) : 513 - 519
[7] INTERACTION OF PI3K/AKT AND WNT/BETA-CATENIN PATHWAYS IN ACUTE LYMPHOBLASTIC LEUKEMIA
Langhammer, T. S.
Schult, C.
Krohn, S.
Huebner, R.
Rolfs, A.
Junghanss, C.
ANNALS OF HEMATOLOGY, 2013, 92 : S22 - S22
[8] Dual PI3K/Akt/mTOR Pathway Inhibitor Potentiate Cytarabine Cytotoxicity For Acute Myeloid Leukemia
Kim, Eun Kyung
Kang, Hyoung Jin
Kim, Hyung Joon
Lee, Ji Won
Kim, Hyery
Park, Kyung Duk
Shin, Hee Young
Ahn, Hyo Seop
BLOOD, 2013, 122 (21)
[9] Withanolide Metabolites Inhibit PI3K/AKT and MAPK Pro-Survival Pathways and Induce Apoptosis in Acute Myeloid Leukemia Cells
Akhtar, Nosheen
Baig, Muhammad Waleed
Haq, Ihsan-ul
Rajeeve, Vinothini
Cutillas, Pedro Rodriguez
BIOMEDICINES, 2020, 8 (09)
[10] mTORC1 Activity Is Independent of PI3K/Akt but Controlled by AMPK in Acute Myeloid Leukemia
Green, Alexa Samantha
Tamburini, Jerome
Willems, Lise
Chapuis, Nicolas
Park, Sophie
Bardet, Valerie
Foretz, Marc
Viollet, Benoit
Ifrah, Norbert
Dreyfus, Francois
Mayeux, Patrick
Lacombe, Catherine
Bouscary, Didier
BLOOD, 2008, 112 (11) : 345 - 346

← 1 2 3 4 5 →